Plexaa Ltd


Plexāā is a UK-based MedTech company developing a wearable, sensor-controlled thermal preconditioning device and a companion digital app to support preoperative preparation (Prehab) for breast surgery. The company combines device engineering, clinical studies, and a digital support platform to reduce wound-healing complications and integrate prehabilitation into perioperative care pathways. Plexāā has engaged regulatory and quality assurance processes for its digital product, secured contract manufacturing partnerships, participated in accelerator programs, and reported proof-of-concept clinical evidence.

Industries

N/A

Nr. of Employees

small (1-50)


Patents

Heating device

US-11883321-B2

View Details

Products

Wearable thermal preconditioning device

A hands-free, non-invasive, drug-free wearable intended for home use to deliver ultra-precise thermal preconditioning to skin prior to surgery to increase local blood flow and tissue resilience.

Prehab & Rehab digital program (companion app)

Personalised 8-week pre- and post-surgery program delivered through a mobile app, including expert content on nutrition, movement, mindfulness and sleep, plus community and clinician-led sessions.


Services

Pilot implementations and care-pathway integration for perioperative use of a wearable preconditioning device and companion app; partnerships with surgical centres for prescribing and implementation.

Free mobile application offering evidence-based content, personalised prehab and rehab plans, symptom tracking, secure uploads, community support, and live expert sessions.

Expertise Areas

  • Prehabilitation and perioperative care
  • Wearable medical device development
  • Digital health app development and clinical content
  • Clinical trial execution and evidence generation
  • Show More (4)

Key Technologies

  • Sensor-controlled thermal therapy (wearable)
  • Thermal preconditioning / heat-shock protein stimulation
  • Wearable medical device engineering
  • Mobile health application platform
  • Show More (2)

News & Updates

Announcement of the U.S. launch of the combined wearable preconditioning device and companion app, and availability to hospitals, surgical centres and clinics in the U.S.

Raised a $4.5 million funding extension to support U.S. commercial launch and platform development, including backing from institutional and grant funders.

Partnership with a contract manufacturer to scale production of the wearable device, with manufacturing expected to begin for initial batches.

Independent ORCHA assurance awarded after evaluation across global standards for clinical assurance, data privacy, and usability.

Digital Health Assessment Framework (DHAF) assurance confirming compliance with clinical, data privacy, and usability criteria aligned with US frameworks.

Recognised as 'FemTech Product of the Year' for the wearable preconditioning device at the MedTech World Awards.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.